Search

Your search keyword '"Savoye, Guillaume"' showing total 810 results

Search Constraints

Start Over You searched for: Author "Savoye, Guillaume" Remove constraint Author: "Savoye, Guillaume"
810 results on '"Savoye, Guillaume"'

Search Results

4. Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID

5. Adalimumab in Biologic-naïve Patients With Crohn’s Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAID

7. Prevalence of and Factors Associated With Extraintestinal Manifestations and Their Remission in Inflammatory Bowel Disease: The EXTRA-Intestinal Manifestation Prospective Study From the Groupe dʼEtude Thérapeutique des Affections Inflammatoires du Tube Digestif

10. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

11. COMPARISON OF NORMAL VS INTENSIFIED VACCINE REGIMENS AGAINST PNEUMOCOCCUS IN CD PATIENTS UNDER BIOTHERAPY: A PROSPECTIVE, MULTICENTER, RANDOMIZED, OPEN-LABEL, PNEUMOMICI STUDY

12. Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or Cyclosporine

13. Patients’ real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group

14. Lymphoma in Patients with Inflammatory Bowel Disease: A Multicentre Collaborative Study Between GETAID and LYSA

15. Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID.

17. Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis

21. Efficacy of ferric carboxymaltose on haemoglobin response among older patients with gastrointestinal bleeding: a randomised clinical trial.

22. Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAID.

24. Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa.

26. High Risk of Anal and Rectal Cancer in Patients With Anal and/or Perianal Crohn’s Disease

27. Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn’s Disease in Sustained Remission

28. Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases

32. Prevalence of and factors associated with extraintestinal manifestations and their remission in inflammatory bowel disease: the EXTRA prospective study from the GETAID

33. Increased Risk of Cancer and Mortality in a Large French Population-Based Paediatric-Onset Inflammatory Bowel Disease Retrospective Cohort

34. Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID.

35. A Novel 8-Predictors Signature to Predict Complicated Disease Course in Pediatric-onset Crohn’s Disease: A Population-based Study

36. New therapeutic strategies are associated with a significant decrease in colectomy rate in pediatric ulcerative colitis

37. Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study

38. Natural History of Anal Ulcerations in Pediatric-Onset Crohn's Disease: Long-Term Follow-Up of a Population-Based Study

39. Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease

40. Prevalence and determinants of fatigue in patients with IBD: a cross-sectional survey from the GETAID

42. Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn′s Disease: A French Population-Based Study

43. Adalimumab in Biologic-naïve Patients With Crohn’s Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAID

44. Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study

45. Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic Strictures

46. Incidence, Clinical Presentation, and Associated Factors of Microscopic Colitis in Northern France: A Population-Based Study

47. Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study

48. Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV‐IBD cohort

49. Efficacy of adalimumab in patients with Crohnʼs disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study

50. Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases

Catalog

Books, media, physical & digital resources